Neoadjuvant immunotherapy for advanced, resectable non–small cell lung cancer: A systematic review and meta‐analysis
2023 · Cancer · 34 citations
https://doi.org/10.1002/cncr.34755
Q
Qiang Lin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
75
Papers
443
Citations
12
h-index
14
i10-index
Qiang Lin is an academic researcher from Hebei Medical University. The author has contributed to research in topics: Lung Cancer Diagnosis and Treatment & Lung Cancer Treatments and Mutations & Esophageal Cancer Research and Treatment. The author has an h-index of 12, co-authored 64 publications.
ORCID: 0000-0001-9599-4121Papers by this author
worksHigh-dose accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy/fraction) with concurrent vinorelbine and carboplatin chemotherapy in locally advanced non-small-cell lung cancer: a feasibility study
2013 · Radiation Oncology · 25 citations
https://doi.org/10.1186/1748-717x-8-198
Accelerated hypofractionated three-dimensional conformal radiation therapy (3 Gy/fraction) combined with concurrent chemotherapy for patients with unresectable stage III non-small cell lung cancer: preliminary results of an early terminated phase II trial
2016 · BMC Cancer · 25 citations
https://doi.org/10.1186/s12885-016-2314-1
Phase II clinical trial of whole-brain irradiation plus three-dimensional conformal boost with concurrent topotecan for brain metastases from lung cancer
2013 · Radiation Oncology · 20 citations
https://doi.org/10.1186/1748-717x-8-238
Treatment-related pneumonitis after thoracic radiotherapy/chemoradiotherapy combined with anti-PD-1 monoclonal antibodies in advanced esophageal squamous cell carcinoma
2024 · Strahlentherapie und Onkologie · 2 citations
https://doi.org/10.1007/s00066-024-02199-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat